0001209191-21-049302.txt : 20210803 0001209191-21-049302.hdr.sgml : 20210803 20210803161602 ACCESSION NUMBER: 0001209191-21-049302 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210802 FILED AS OF DATE: 20210803 DATE AS OF CHANGE: 20210803 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Torres Denice CENTRAL INDEX KEY: 0001820278 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38459 FILM NUMBER: 211139948 MAIL ADDRESS: STREET 1: 3 RABBIT RUN DRIVE CITY: NEW HOPE STATE: PA ZIP: 18938 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Surface Oncology, Inc. CENTRAL INDEX KEY: 0001718108 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 50 HAMPSHIRE STREET, 8TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 617-714-4096 MAIL ADDRESS: STREET 1: 50 HAMPSHIRE STREET, 8TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-08-02 0 0001718108 Surface Oncology, Inc. SURF 0001820278 Torres Denice C/O SURFACE ONCOLOGY, INC. 50 HAMPSHIRE STREET, 8TH FLOOR CAMBRIDGE MA 02139 1 0 0 0 Stock Option (Right to Buy) 6.10 2021-08-02 4 A 0 36000 0.00 A 2031-08-02 Common Stock 36000 36000 D The options shall vest ratably over three years following July 6, 2021, so long as the grantee remains a director or other service provider of the Company on such dates. /s/ Jessica Fees, Attorney-in-Fact 2021-08-03